As the Trump administration continues to make significant cuts to NIH budgets and personnel and to freeze billions of dollars ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

The biotech has quickly turned a cell therapy approval into one of the more lucrative recent sales for a priority review ...

The U.S. Food and Drug Administration said Saturday thatlofficials are investigating the outbreak linked to foods produced by ...

According to the FDA, tianeptine has a high potential for abuse with serious harmful effects by itself or with other drugs, ...

A joint investigation by the U.S. Food and Drug Administration, Centers for Disease Control and Prevention, and state and ...

Intellia Therapeutics reported further progress with two treatments that are now ensconced in Phase III of testing. Click ...

Eli Lilly's tirzepatide leads to 50% more weight loss compared to Novo Nordisk's semaglutide in 72-week study.

The order is a blow to the pharmaceutical industry, which is already bracing for Trump’s planned tariffs on prescription ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

A. Thank you for sharing your long and challenging pain path with migraine headaches. Aimovig (erenumab) is a self-injectable ...